Rezatomidine

DB12143InvestigationalSmall molecule

Rezatomidine has been used in trials studying the treatment of Fibromyalgia, Cystitis, Interstitial, Irritable Bowel Syndrome, and Diabetic Neuropathy, Painful.

Chemical structure of Rezatomidine
Formula / weight
C13H16N2S · 232.35 g/mol (avg)
Code names
Agn 203818

Resolves to

Compound
UNIIW5LMZ0RC8ICAS847829-38-3ChEMBLCHEMBL2107366PubChem11287722
Structure
InChIKeyWQXVKEDUCPMRRI-JTQLQIEISA-NSMILESC[C@H](C1=CNC(=S)N1)C1=C(C)C(C)=CC=C1
Targets
P18825ADRA2C

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Rezatomidine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In